Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000177367 | SCV000229216 | benign | not specified | 2015-04-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001651043 | SCV001867409 | benign | not provided | 2021-03-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001651043 | SCV002406699 | benign | not provided | 2025-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002326973 | SCV002632579 | likely benign | Inborn genetic diseases | 2018-05-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001651043 | SCV004142362 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | RAI1: BP4, BS1 |
Breakthrough Genomics, |
RCV001651043 | SCV005248528 | benign | not provided | criteria provided, single submitter | not provided |